News for 'Drug Administration'

DCGI takes BIG step for rollout of foreign vaccines in India

DCGI takes BIG step for rollout of foreign vaccines in India

Rediff.com2 Jun 2021

"It has been decided that for approval of COVID-19 vaccines in India for restricted use in emergency situation which are already approved for restricted use by US Food Drug Administration, European Medicines Agency, UK Medicines and Healthcare products Regulatory Agency, Pharmaceuticals and Medical Devices Agency Japan or which are listed in WHO Emergency Use Listing and which are well established vaccines from the stand point that millions of individuals have already been vaccinated with the said vaccines, the requirement of conducting post approval bridging clinical trials and of testing every batch of vaccine by CDL, Kasauli can be exempted, if the vaccine batch/lot has been certified and released by National Control Laboratory of country of origin," it said.

India probes four cough syrups after 66 Gambian children's deaths

India probes four cough syrups after 66 Gambian children's deaths

Rediff.com6 Oct 2022

India's drug regulator has initiated a probe and sought further details from the WHO after the global health body issued an alert that cough syrups manufactured by an Indian firm could potentially be linked to the death of children in Gambia.

Uddhav strips 9 rebel ministers of portfolios, reassigns to others

Uddhav strips 9 rebel ministers of portfolios, reassigns to others

Rediff.com27 Jun 2022

Maharashtra Chief Minister Uddhav Thackeray has handed over portfolios of nine rebel ministers, who are currently camping in Guwahati, to other ministers.

India reacts as US cop who killed Jaahnavi Kandula goes scot-free

India reacts as US cop who killed Jaahnavi Kandula goes scot-free

Rediff.com24 Feb 2024

In bodycam footage released by the Seattle Police Department, Officer Daniel Auderer laughed about the deadly crash and dismissed any implication Dave might be at fault or that a criminal investigation was necessary.

EC cracks the whip, shifts lax officials including cops in 5 poll-bound states

EC cracks the whip, shifts lax officials including cops in 5 poll-bound states

Rediff.com11 Oct 2023

During a review, the EC found that the performance of some officers was "unsatisfactory" and they were found "complacent, if not complicit" in various matters, including the illegal supply of liquor as a possible poll inducement, sources said.

Ranbaxy drugs cleared FDA test before import alert

Ranbaxy drugs cleared FDA test before import alert

Rediff.com11 Jun 2013

FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.

Will recommend central rule, governor Purohit warns Punjab CM Mann

Will recommend central rule, governor Purohit warns Punjab CM Mann

Rediff.com25 Aug 2023

In a major escalation of the tussle with Punjab Chief Minister Bhagwant Mann, Governor Banwarilal Purohit on Friday warned that he could recommend President's rule in the state and also initiate criminal proceedings if his letters are not answered.

Why Is USFDA Inspecting India Pharma Firms?

Why Is USFDA Inspecting India Pharma Firms?

Rediff.com30 Dec 2022

Indian drug firms continue to work closely with the FDA, and most have also appointed consultants to help them grasp the regulatory minutiae in the US.

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Rediff.com14 Mar 2023

In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. This trend has continued in the current year, with year-to-date return remaining in the negative (-4.9 per cent). In the past three months, pharma funds have been hit hard, experiencing a 7.9 per cent decline.

After US, Germany bans export of Ranbaxy's Dewas plant drugs

After US, Germany bans export of Ranbaxy's Dewas plant drugs

Rediff.com3 Dec 2014

The company did not comply to the 'good manufacturing practice' norms.

India raises concerns over FDA actions on domestic drug firms

India raises concerns over FDA actions on domestic drug firms

Rediff.com10 Feb 2014

India on Monday raised serious concerns over the USFDA's audit inspections of Indian pharma companies and 'disproportionate penalties' in some instances and said it would submit a discussion document on the issues to the US.

Bihar cops obtain reference NEET papers, ED likely to join probe

Bihar cops obtain reference NEET papers, ED likely to join probe

Rediff.com22 Jun 2024

The Bihar Police's Economic Offences Unit, which is probing the alleged National Eligibility-cum-Entrance Test (Undergraduate) (NEET-UG) paper leak case, on Saturday claimed to have obtained reference question papers of the test conducted by National Testing Agency (NTA) and planned to compare these with documents recovered from a flat in Patna during a search operation last month.

Cadila launches Remdesivir in India at Rs 2,800 per vial

Cadila launches Remdesivir in India at Rs 2,800 per vial

Rediff.com13 Aug 2020

The company said the drug will be made available across India through the group's strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

India acts to repair reputation as drugs exporter

India acts to repair reputation as drugs exporter

Rediff.com7 May 2014

As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.

Why drug firms' Q2 revenue growth is likely to dip

Why drug firms' Q2 revenue growth is likely to dip

Rediff.com12 Oct 2018

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.

Medical devices to be treated as drugs from next fiscal

Medical devices to be treated as drugs from next fiscal

Rediff.com12 Feb 2020

The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of compliance.

International drug ring busted

International drug ring busted

Rediff.com21 Apr 2005

Govt drafts rules to help COVID-19 patients access new drugs

Govt drafts rules to help COVID-19 patients access new drugs

Rediff.com8 Jun 2020

According to a gazette notification of the draft rules published on June 5, a hospital or medical institution may import new drug for 'compassionate use for treatment of patients suffering from life threatening disease or disease causing serious permanent disability or disease requiring therapy for unmet medical need', which has not been permitted in the country, but under Phase-III clinical trial (human trial) in the country or abroad, by making an application to the Central Drug Regulator.

RAW official behind Pannun murder plot? Here is what media report says

RAW official behind Pannun murder plot? Here is what media report says

Rediff.com29 Apr 2024

Quoting officials, The Washington Post said, the foiled assassination was part of an escalating campaign of aggression by RAW against the Indian diaspora in Asia, Europe and North America.

Previous infection doesn't protect kids from Omicron: Study

Previous infection doesn't protect kids from Omicron: Study

Rediff.com30 May 2022

Children who previously had COVID-19 or the inflammatory condition MIS-C are not protected against the Omicron variant of coronavirus, according to a study which found vaccination, however, does afford protection.

Indian drug cos to benefit as US expedites generic clearances

Indian drug cos to benefit as US expedites generic clearances

Rediff.com12 May 2014

Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.

Aussie regulator probes Ranbaxy

Aussie regulator probes Ranbaxy

Rediff.com4 Mar 2009

Australian health regulator Therapeutic Goods Administration is investigating Indian pharma major Ranbaxy, following US allegations of the company falsifying data and test results of new drug applications, a media report says.

Indian-origin student found dead in US, shot self in head

Indian-origin student found dead in US, shot self in head

Rediff.com8 Feb 2024

Sameer Kamath, a US citizen, was found dead in the woods on February 5 at approximately 5pm in NICHES Land Trust - Crow's Grove in Williamsport, Indiana.

Biden, Trump sweep Super Tuesday primaries, rematch is on

Biden, Trump sweep Super Tuesday primaries, rematch is on

Rediff.com6 Mar 2024

Super Tuesday is an important phase of presidential primaries when the early contests are over, and voters from multiple states cast ballots in primaries timed to occur on the same date. Almost all the results were one-sided in favour of Trump except for Vermont, where the winning difference was about one per cent.

Parliament breach: Five accused taken to Gujarat for polygraph, narco tests

Parliament breach: Five accused taken to Gujarat for polygraph, narco tests

Rediff.com9 Jan 2024

The police officials said all the five accused will have to undergo the polygraph test, while Sagar and Manoranjan will have to undergo additional naro-analysis and brain mapping tests.

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Rediff.com21 Aug 2020

Baltimore-based Lupin Pharmaceuticals Inc is recalling 5,60,922 pouches of Mibelas 24 Fe (norethindrone acetate and Ethinyl estradiol tablets and ferrous fumarate tablets) in the US, as per the latest enforcement report by the USFDA.

As drug firms squirm, authorities look abroad for cure

As drug firms squirm, authorities look abroad for cure

Rediff.com23 Sep 2013

DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices

SIIto test Novavax's Omicron-specific vaccine

SIIto test Novavax's Omicron-specific vaccine

Rediff.com6 Jun 2022

The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for 'examination, test, and analysis', reports Sohini Das.

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.

Pfizer Covid vaccine gets US experts' nod

Pfizer Covid vaccine gets US experts' nod

Rediff.com11 Dec 2020

The Pfizer vaccine has already been approved for the public in the United Kingdom and, Canada.

Covovax nod to boost vaccination drive in India: SII

Covovax nod to boost vaccination drive in India: SII

Rediff.com28 Dec 2021

Vaccine major Serum Institute of India on Tuesday said the approval for the COVID-19 vaccine 'Covovax' would strengthen immunization initiatives across India and various lower and middle income countries across the world.

Policy tweaks in US shift Indian pharma's focus

Policy tweaks in US shift Indian pharma's focus

Rediff.com18 Jun 2014

As marketing rights for off-patent drugs in the US become less exclusive, companies are scrambling for fresh strategies to make up for the revenue loss.

Sharapova's intent questioned - Why was she taking banned heart drug?

Sharapova's intent questioned - Why was she taking banned heart drug?

Rediff.com9 Mar 2016

'Sharapova has been a US resident since early in her career, which does bring in a question of how or why she is using a drug that is not licensed there'

Can 'Singham Anna' Deliver For The BJP?

Can 'Singham Anna' Deliver For The BJP?

Rediff.com17 Apr 2024

Annamalai has faced criticism for the breakup between the AIADMK and the BJP, but BJP leaders say 'he attracts youth, who needs change'.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

Wockhardt Q1 net profit dips 94% to Rs 19.95 crore

Wockhardt Q1 net profit dips 94% to Rs 19.95 crore

Rediff.com12 Aug 2014

The company had posted a consolidated net profit of Rs 323.31 crore (Rs 3.23 billion) in the same period last fiscal, Wockhardt Ltd said in a filing to the Bombay Stock Exchange.

Covid vax didn't increase risk of sudden death among young: Govt

Covid vax didn't increase risk of sudden death among young: Govt

Rediff.com8 Dec 2023

A study conducted by the Indian Council of Medical Research (ICMR) has observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, the government informed Parliament on Friday.

PIL in Supreme Court for action against Ranbaxy

PIL in Supreme Court for action against Ranbaxy

Rediff.com5 Jun 2013

An advocate on Wednesday approached the Supreme Court with a PIL seeking cancellation of the license granted to Ranbaxy Laboratories and for initiating probe against the pharma major for allegedly manufacturing and selling adulterated drugs.

GSK withdraws sale of Zinetac after health alert

GSK withdraws sale of Zinetac after health alert

Rediff.com26 Sep 2019

GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

A Mylan win in US court could hit Ranbaxy

A Mylan win in US court could hit Ranbaxy

Rediff.com4 Oct 2012

Ranbaxy was scheduled to launch its drug on September 21, the day Diovan's patent expired.